Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 1, 2003
In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substanceSusanne Bredenberg, Margareta Duberg, Bo Lennernäs, et al.
Molecular and Clinical Oncology|February 2, 2018
Effect on prostate volume following neoadjuvant treatment with an androgen receptor inhibitor monotherapy versus castration plus an androgen receptor inhibitor in prostate cancer patients intended for curative radiation therapy: A randomised studyKhairul Majumder, Yvonne Brandberg, Hemming Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2016
Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up studyKhairul Majumder, Sten Nilsson, Hemming Johansson, et al.
Palliative Medicine|December 18, 2009
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II studyBo Lennernäs, Ingela Frank-Lissbrant, Hans Lennernäs, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2006
Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometryAnnica Tevell, Hans Lennernäs, Mats Jönsson, et al.
International Journal of Oncology|October 31, 2014
Long-term health-related quality of life after curative treatment for prostate cancer: a regional cross-sectional comparison of two standard treatment modalitiesMarie Hjälm-Eriksson, Bo Lennernäs, Anders Ullén, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2005
Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acidAnders Ullén, Lena Lennartsson, Ulrika Harmenberg, et al.
Acta Oncologica (Stockholm, Sweden)|September 9, 2021
High rate of local control and cure at 10 years after treatment of prostate cancer with external beam radiotherapy and high-dose-rate brachytherapy: a single centre experienceMarie Hjälm-Eriksson, Sten Nilsson, Yvonne Brandberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 28, 2008
High precision transponder localization using a novel electromagnetic positioning system in patients with localized prostate cancerJon Kindblom, Ann-Marie Ekelund-Olvenmark, Hanna Syren, et al.
Molecular Pharmaceutics|July 24, 2014
Pharmacokinetics of an injectable modified-release 2-hydroxyflutamide formulation in the human prostate gland using a semiphysiologically based biopharmaceutical modelErik Sjögren, Teuvo L Tammela, Bo Lennernäs, et al.
Pageof 4